The GW Vaccine Research Unit
supported by the University Seminar Series Program
present the
Seminar Series: State of the Art Topics In Vaccinology
“Developing Vaccines that Induce Broadly Neutralizing Antibodies to Prevent Infection with HIV ”
Featuring: Marina Caskey, MD
Marina Caskey, MD is a Professor of Clinical Investigation at The Rockefeller University. Her work focuses on the development and clinical evaluation of novel immunotherapeutic strategies against infectious diseases, with a special emphasis on HIV. Caskey has led a series of clinical studies to evaluate the safety and efficacy of broadly neutralizing anti-HIV antibodies. These studies have revitalized this area of HIV research, which had been abandoned after first-generation antibodies failed to show significant effects in humans. Broadly neutralizing antibodies are now considered one of the most promising strategies to achieve HIV remission, as well as potential alternatives to antiretrovirals for both therapy and prevention.
She currently serves as Chair of the Reservoirs Remission and Cure Transformative Science Group of the AIDS Clinical Trials Group (ACTG) and co-leads one of the Martin Delaney Collaboratories for HIV Cure, called REACH. She is an Associate Director of the Einstein-Rockefeller-CUNY Center for AIDS Research.
Caskey graduated from medical school at the Federal University of Sergipe in Brazil. She then completed an internal medicine residency at Saint Luke’s Roosevelt Hospital, in New York, followed by fellowship training in infectious diseases at New York Presbyterian-Weill Cornell Medical Center. She is also an attending physician in infectious diseases at Weill Cornell Medicine Center and an elected member of the American Society of Clinical Investigation.